BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23002446)

  • 41. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland.
    Sadowy E; Matynia B; Hryniewicz W
    J Antimicrob Chemother; 2010 Sep; 65(9):1907-14. PubMed ID: 20584746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term surveillance of group B
    Le Gallou B; Pastuszka A; Lemaire C; Perrotin F; Mitanchez D; Lanotte P; Mereghetti L
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37335614
    [No Abstract]   [Full Text] [Related]  

  • 43. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults.
    Baker CJ; Rench MA; Paoletti LC; Edwards MS
    Vaccine; 2007 Jan; 25(1):55-63. PubMed ID: 16919857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype.
    Jones N; Oliver KA; Barry J; Harding RM; Bisharat N; Spratt BG; Peto T; Crook DW;
    Clin Infect Dis; 2006 Apr; 42(7):915-24. PubMed ID: 16511753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune Responses to Invasive Group B Streptococcal Disease in Adults.
    Edwards MS; Rench MA; Rinaudo CD; Fabbrini M; Tuscano G; Buffi G; Bartolini E; Bonacci S; Baker CJ; Margarit I
    Emerg Infect Dis; 2016 Nov; 22(11):1877-1883. PubMed ID: 27767008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the Diversilab® system with multi-locus sequence typing and pulsed-field gel electrophoresis for the characterization of Streptococcus agalactiae invasive strains.
    Al Nakib M; Longo M; Tazi A; Billoet A; Raymond J; Trieu-Cuot P; Poyart C
    J Microbiol Methods; 2011 May; 85(2):137-42. PubMed ID: 21338630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD.
    Toniolo C; Balducci E; Romano MR; Proietti D; Ferlenghi I; Grandi G; Berti F; Ros IM; Janulczyk R
    J Biol Chem; 2015 Apr; 290(15):9521-32. PubMed ID: 25666613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk Factors for Infant Colonization by Hypervirulent CC17 Group B Streptococcus: Toward the Understanding of Late-onset Disease.
    Tazi A; Plainvert C; Anselem O; Ballon M; Marcou V; Seco A; El Alaoui F; Joubrel C; El Helali N; Falloukh E; Frigo A; Raymond J; Trieu-Cuot P; Branger C; Le Monnier A; Azria E; Ancel PY; Jarreau PH; Mandelbrot L; Goffinet F; Poyart C
    Clin Infect Dis; 2019 Oct; 69(10):1740-1748. PubMed ID: 30946447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.
    Bianchi-Jassir F; Paul P; To KN; Carreras-Abad C; Seale AC; Jauneikaite E; Madhi SA; Russell NJ; Hall J; Madrid L; Bassat Q; Kwatra G; Le Doare K; Lawn JE
    Vaccine; 2020 Oct; 38(43):6682-6694. PubMed ID: 32888741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
    Hillier SL; Ferrieri P; Edwards MS; Ewell M; Ferris D; Fine P; Carey V; Meyn L; Hoagland D; Kasper DL; Paoletti LC; Hill H; Baker CJ
    Clin Infect Dis; 2019 May; 68(12):2079-2086. PubMed ID: 30281066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phylogeny, recombination, and invasiveness of group B Streptococcus revealed by genomic comparisons of its global strains.
    Lin E; Zou S; Wang Y; Lee CC; Chiu CH; Feng Y
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):581-590. PubMed ID: 33067737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.
    Chaffin DO; Mentele LM; Rubens CE
    J Bacteriol; 2005 Jul; 187(13):4615-26. PubMed ID: 15968073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.
    Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Edwards MS; Kasper DL
    J Infect Dis; 2004 Mar; 189(6):1103-12. PubMed ID: 14999615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular epidemiology of invasive neonatal Streptococcus agalactiae isolates in Germany.
    von Both U; John A; Fluegge K; Siedler A; Berner R
    Pediatr Infect Dis J; 2008 Oct; 27(10):903-6. PubMed ID: 18756182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycoconjugate vaccines to prevent group B streptococcal infections.
    Paoletti LC; Kasper DL
    Expert Opin Biol Ther; 2003 Sep; 3(6):975-84. PubMed ID: 12943456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci.
    Poyart C; Tazi A; Réglier-Poupet H; Billoët A; Tavares N; Raymond J; Trieu-Cuot P
    J Clin Microbiol; 2007 Jun; 45(6):1985-8. PubMed ID: 17376884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different sequence strains of Streptococcus agalactiae elicit various levels of cytokine production.
    De Francesco MA; Gargiulo F; Negrini R; Gelmi M; Manca N
    Immunol Invest; 2008; 37(8):741-51. PubMed ID: 18991093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel Multiplex Immunoassays for Quantification of IgG against Group B
    Buffi G; Galletti B; Stella M; Proietti D; Balducci E; Romano MR; Mori E; Fabbrini M; Giuliani MM; Berti F; Margarit I
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clustered Regularly Interspaced Short Palindromic Repeat Analysis of Clonal Complex 17 Serotype III Group B
    Hsu JF; Lu JJ; Lin C; Chu SM; Lin LC; Lai MY; Huang HR; Chiang MC; Tsai MH
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.